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Abstract
Introduction: Underdiagnosis of COPD seems to be a relevant clinical and social problem. We hypothesized that active public 
spirometry campaign may help identify subjects with airflow limitation consistent with COPD.
The aim of the study was (1) to evaluate the willingness of random smokers to undergo public spirometry, (2) to assess the ability 
to obtain an acceptable quality spirometry during a public campaign, and (3) to assess the relationships between the presence 
and severity of respiratory symptoms and readiness to undergo spirometry. 
Material and methods: Pedestrians aged > 40 years and a smoking history > 10 pack-years were recruited by medical students 
to fill a questionnaire and perform spirometry. Those with obstructive or borderline ventilatory insuffciency were invited and 
encouraged to undergo stationary spirometry in a pulmonary outpatient department.
Results: Nine hundred and five subjects meeting the inclusion criteria were invited to the study. Only 178 subjects agreed to 
complete the questionnaire and undergo spirometry. Airway obstruction and borderline spirometry result (classified as possible 
airway obstruction) were found in 22 and 37 subjects, respectively. Of these, only 15 patients attended follow-up visit to verify 
public spirometry results. Extrapolation of the limited data showed the incidence of newly diagnosed airway obstruction as 10.7%. 
Conclusions: Public spirometry campaign does not seem to be an effective way of COPD screening. Smokers are reluctant to 
undergo complimentary spirometry even in the presence of pronounced respiratory symptoms. Our observations may be helpful 
in elaborating future screening programs for COPD.
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Introduction
Chronic obstructive pulmonary disease 
(COPD) is a common entity characterized by per-
sistent airflow limitation and respiratory symp-
toms [1]. According to one recent meta-analysis 
of 123 studies, the prevalence of COPD in people 
aged 30 years or older was approximately 11.7% 
(95% confidence interval [CI] 8.4–15.0%) [2]. With 
more than 3 million people dying of COPD every 
year [3] the disease is currently the fourth world 
leading cause of death and is estimated to become 
the third in the next several years [1].
Polish epidemiological data on COPD are 
consistent with those reported from other co-
untries. Three studies showed the prevalence 
of COPD in Polish population aged > 40 years 
ranging between 10.7 and 22.1% [4–6]. As in 
other countries, an early diagnosis seems to 
be one of the major issue in management of 
COPD. Bednarek et al. [5] showed that in pri-
mary care setting only less than 20% of patients 
with COPD had been diagnosed. Most of these 
patients had severe and very severe airflow 
limitation. Thus, it might be estimated that 
about 80% of COPD patients in Poland suffered 
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from mild or moderate disease and had been 
underdiagnosed [7].
As smoking is a major risk factor for COPD, it 
may seem that the identification of the population 
at particular risk of COPD development should 
be relatively simple. One recent Polish study 
showed that approximately 30% of men and 21% 
surveyed in 2014 were current smokers [8]. These 
patients should probably be a target for screening 
campaigns aimed at an early diagnosis of airway 
obstruction and COPD. However, it has been well 
documented that asymptomatic smokers or smo-
kers with mild symptoms only rarely seek medical 
attention. Moreover, primary care providers do 
not always have access, enough time or adequate 
training to use spirometry, which is crucial for 
diagnosis of persistent airflow limitation. Thus, 
albeit early detection and proper intervention for 
COPD could potentially slow the progression of 
the disease and minimize its negative consequ-
ences [9], spirometry is probably still performed 
too rarely to significantly increase the proportion 
of patients diagnosed with early COPD stages. We 
believe that social campaigns, including those 
carried out by medical students, may increase 
public awareness of COPD, contribute to more 
effective smoking cessation and more effective 
COPD diagnosis in patients with mild symptoms.
Therefore, we undertook a study aimed at:
1. The evaluation of willingness of random 
smokers to undergo public spirometry.
2. The assessment of ability to obtain an accep-
table quality spirometry during a public cam-
paign, which could be a prerequisite for the 
diagnosis of airway obstruction and COPD. 
3. The assessment of the relationships between 
readiness to undergo free of charge spirome-
try and the presence and severity of respira-
tory symptoms. 
Material and methods
Study design and patient characteristics
This prospective, cross-sectional study was 
conducted between January and May 2016. The 
recruitment to the study was performed at the 
Warsaw East Railway Station and included pede-
strians who were asked and encouraged to parti-
cipate in the study. The specific inclusion criteria 
were as follows: 1) age > 40 years; 2) a smoking 
history > 10 pack-years; 3) consent to take part in 
the study. Subjects with symptoms of acute respi-
ratory tract infection in the previous 6 weeks and 
those who did not give their consent to participate 
in the study were excluded. The participants who 
were active smokers or who had quitted smoking 
in the last 12 months were classified as current 
smokers. Subjects who had a  smoking history 
> 10 pack-years but who had not smoked for more 
than 12 months were classified as ex-smokers.
A stand was prepared and driven by the me-
dical students. The students actively searched 
and recruited the study participants. All sub-
jects who met the inclusion criteria and signed 
the informed consent to participate in the study 
were asked to fill a questionnaire that contained 
questions on demographic data, exposure to 
active and passive smoking, comorbidities and 
respiratory symptoms. Participants who agreed 
to perform spirometry, but were non-smokers 
or < 40 years of age were excluded from study. 
Quantitative assessment of symptoms included 
the COPD Assessment Test (CAT) and the modi-
fied Medical Research Council (mMRC) dyspnea 
scale. Based on the results of the above tests, the 
patients were classified as having low (mMRC 
score 0–1 and CAT score < 10) or high level of 
symptoms (mMRC ≥ 2 or CAT score ≥ 10, respec-
tively) [1]. A portable spirometer (MicroLab 3500, 
CareFusion, San Diego, California) was used to 
perform a public spirometry. The measurements 
were performed by properly trained medical stu-
dents in accordance with the recommendations 
of the European Respiratory Society (ERS) and 
American Thoracic Society (ATS) [10, 11]. Re-
ference values published by the European Coal 
and Steel Community (ECCS) were applied [12].
To simplify the assessment of public spiro-
metry fixed FEV1/FVC ratio below 0.7 was used 
to diagnose airway obstruction. This approach 
was concordant with GOLD recommendations [1]. 
However, to minimize the risk of false negative 
diagnosis of airway obstruction, the spirometry 
results with FEV1/FVC ratio ≥ 0.7 but only in sub-
jects with symptoms suggestive for COPD and at 
the same time unable to perform good quality spi-
rometry were also considered as probable airway 
obstruction. Thus, based on public spirometry 
the patients were classified as follows: no airflow 
limitation group (N) characterized by FEV1/FVC 
ratio ≥ 0.7 and no respiratory symptoms, airway 
obstruction group (AO) defined as FEV1/FVC ratio 
< 0.7 and possible airway obstruction group (PAO) 
defined as FEV1/FVC ratio < 0.7 and FEV1/FVC 
ratio ≥ 0.7 and below LLN in symptomatic patients 
unable to perform spirometry of good quality. 
In order to verify the results of public spiro-
metry all participants from AO and PAO groups 
were strongly encouraged to visit a Pulmonary 
Function Test (PFT) Unit of the Medical Universi-
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ty of Warsaw in order to undergo a free of charge 
spirometry carried out by qualified medical staff 
and to be seen by pulmonary specialist. The sub-
jects asked to consult the doctor at the medical 
centre were inhabitants of the city, where the 
test was performed. They initially declared the 
responsible will to come for the check-up and 
they could select the appointment date. The au-
thors made every effort to motivate the planned 
group to come for a control spirometry tests. In 
patients who accepted the invitation, spirometry 
with flow-volume curve was performed (Lungtest 
1000, MES, Cracow, Poland) in accordance with 
the recommendations of the ERS/ATS [10, 11]. In 
case of airflow limitation (defined as FEV1/FVC 
< LLN), the bronchial obstruction reversibility 
test was performed according to the respective 
guidelines [11].
The study was approved by the institutional 
review board of the Medical University of Warsaw.
Data presentation and statistical analyses
Statistical analysis was performed using 
Statistica 12.5 (StatSoft Inc., Tulsa, OK, USA) 
and MedCalc 13.2.2 (MedCalc Software bvba, 
Ostend, Belgium) statistical software packages. 
Data are expressed as medians and interquartile 
ranges (IQRs, 25th to 75th percentiles) or numbers 
and percentages. The distribution of categorical 
variables in the independent groups was com-
pared using Fisher’s exact or Chi square tests. 
The differences between continuous variables 
in two or more groups were tested with the use 
of nonparametric Mann-Whitney U-test or Kru-
skal-Wallis test with the subsequent use of the 
post-hoc Dunn test (for multiple comparisons), 
respectively. Statistical significance was accepted 
at p-value less than 0.05.
Results
One thousand fifty five passers-by were asked 
to participate in the study, 150 of them were 
unsuitable (age under 40 years, non-smokers, no 
answer). Finally, nine hundred five persons who 
were smokers and aged above 40 years were invited 
to the study. One hundred seventy eight subjects 
agreed to stop for a while to complete the question-
naire and undergo spirometry. These patients 
formed a baseline study group. The remaining 727 
subjects (80%) refused to collaborate. A detailed 
characteristic of the study group is presented in 
Table 1. Based on the results of public spirometry 
AO and PAO was diagnosed in 22 (12%) and 37 
(21%) patients, respectively. In the remaining 119 
cases (67%), spirometry showed normal results. 
Comparative data of patients with normal spiro-
metry, AO and PAO are shown in Table 1. 
Only 15 (25%) of 59 patients with AO and 
PAO attended the visit in the PFT Unit: 6 parti-
cipants from the AO group (27%) and 9 from the 
PAO group (24%) (Fig. 1). In 5 patients from the 
AO group (83%) and 2 patients from PAO group 
(22%) the airway obstruction was confirmed by 
second spirometry. Thus, airway obstruction was 
confirmed in 7/15 patients with positive screening 
by public spirometry. All patients with confirmed 
airflow limitation had persistent (“fixed”) airway 
obstruction. 
The participants who came for a check-up 
visit were significantly older than subjects who 
did not seek further medical attention. Also, the 
percentage of ex-smokers was significantly higher 
among patients attended follow up visit (Table 2). 
In all 5 patients with known COPD, airway 
obstruction was demonstrated in public spiro-
metry. Two of these patients came for a second 
assessment and persistent airflow limitation was 
confirmed in a  repeated spirometry. In 2 of 5 
patients with known asthma, airway obstruction 
was found in public spirometry, while 3 asthma-
tics had normal spirometry. One of them attended 
the check-up visit and had normal second spiro-
metry. Thus, 5 of 7 (71%) patients with confirmed 
airflow limitation had newly diagnosed airway 
obstruction consistent with diagnosis of COPD. 
The similar severity of bronchial obstruction 
in the public spirometry and stationary spirome-
try was observed. FEV1 and FVC were not signifi-
cantly different during the test performed on the 
railway station and in the PFT Unit (n = 15; p = 
0.16 and 0.64, respectively).
Analysis of symptoms in the study group
Seventy one (40%) and 107 (60%) patients 
who underwent public spirometry had CAT score 
≥ 10 and < 10 points, respectively. The propor-
tion of patients with CAT score ≥ 10 points in AO 
and PAO groups was significantly higher than in 
N group (56% vs. 32%, respectively, p = 0.003) 
(Fig. 2). Ten of 15 patients who attended follow 
up visit and underwent second spirometry repor-
ted CAT score ≥ 10 points, while the remaining 
5 patients < 10 points (p = 0.381). Only 2 of 
these 15 patients had severe dyspnea according 
to mMRC scale. The differences between the 
results of scoring patients with mMRC and CAT 
are presented in Figure 3. Among AO and PAO 
patients, the proportion of symptomatic patients 
evaluated in CAT was significantly higher than 
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Table 1. Comparison of study groups classified according to the results of public spirometry
All subjects
n = 178
N group 
n = 119 
AO group 
n = 22 
PAO group 
n = 37
p
(Kruskal-Wallis 
or Chi square 
test) 
p for multiple 
comparisons: 
N-AO (a),  
N-PAO (b),  
AO-PAO (c)
Age (years) 56 (48–61) 55 (47–60) 60.5 (51–64) 59 (52–63) 0.022 0.08a, 1.0b, 
0.13c
Sex (F/M) 65/113 49/70 7/15 9/28 0.157
BMI (kg/m2) 27.7 
(24.6–30.5)
28.1 
(24.7–31.0)
26.3 
(22.5–30.0)
26.1 
(24.3–30.8)
0.298
FEV1 (L) 2.70 
(2.14–3.34)
2.89 
(2.38–3.66)
2.04 
(1.48–2.58)
2.44 
(2.02–3.05)
0.000 0.015a, 0.16b, 
< 0.001c
FEV1 (% of predicted) 91.5 (76–103.5) 96 (85–110) 71 (56–79) 82 (72–102) 0.000 0.01a, 0.01b, 
<0.001c
FVC (L) 3.78 
(3.16–4.56)
3.84 
(3.16–4.80)
3.73 
(2.50–4.26)
3.65 
(3.25–4.41)
0.406
FVC (% of predicted) 102 (91–115.5) 104 (92–116) 99 (90–102) 103 (87–120) 0.106
FEV1%FVC 73 (67–78) 76 (72–80) 56 (51–65) 69 (66–70) 0.000 < 0.001a, 
0.05b,  
< 0.001c
Ex-smokers/ 
/current smokers (n)
39/139 26/93 2/20 11/26 0.179
Pack-years 28 (18–38) 22.5 (15–36) 33.5 (30–40) 30 (22–40) 0.003 0.01a, 0.19b, 
1.0c
CAT (points) 8 (3–13) 6 (3–12) 11 (8–17) 9 (4–16) 0.013 0.43a, 0.52b, 
0.02c
mMRC 0 (0–1) 0 (0–1) 0.5 (0–1) 0 (0–1) 0.580
COPD n (%) 5 (3) 0 5 (23) 0 (0) 0.000
Asthma n (%) 5 (3) 3 (2.5) 2 (9) 0 0.174
Hypertension n (%) 67 (39) 45 (38) 7 (32) 15 (40.5) 0.798
Ischemic heart disease n (%) 20 (12) 12 (10) 1 (4.5) 7 (19) 0.170
The results are presented as median (IQR) or numbers. For comparisons with no significance in the Kruskal–Wallis test, only one p-value is shown, the left p column; 
for comparisons with significance, p-values are shown for each compared pair, the right p column: a (N vs AO); b (N vs PAO); c (AO vs PAO). 
AO — airway obstruction; BMI — body mass index; CAT — COPD Assessment Test; FEV1 — forced expiratory volume at 1 second; FVC — forced vital capacity; 
mMRC — Medical Research Council scale of dyspnea; N — normal; PAO — possible airway obstruction
patients evaluated according to the mMRC dysp-
nea scale (p < 0.001).
Discussion
Our study is one of the few reports, which 
show the results of public spirometry carried 
out outside a health care setting. We demonstra-
ted that despite an active search for individuals 
at risk, the readiness to take part in a  simple 
screening program that involved a questionna-
ire and public spirometry reached only 20%. In 
178 subjects who entered the screening program 
realized by medical students trained to perform 
and interpret spirometry, airway obstruction and 
possible airway obstruction were found in 33% of 
the respondents. Importantly, only 25% of those 
who were informed about an abnormal spirometry 
result, and were invited to a reference pulmonary 
center to undergo stationary spirometry and to be 
consulted by pulmonary specialist, attended the 
visit. Those patients, who followed the students’ 
advice and came for a second assessment were 
older and were ex-smokers rather than active 
smokers. We did not demonstrate that the severity 
of symptoms was associated with the attendance 
at the follow-up visit in the reference health care 
pulmonary center.
It seems that active campaigns including spi-
rometry screening in high risk populations might 
help to manage the important problem of COPD 
underdiagnosis and, in consequence, to provide 
a more efficient health care for COPD patients. We 
found that our program not only allowed to assess 
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Table 2.  Comparison of the selected clinical data of patients with AO and PAO found in public spirometry who underwent 
and did not undergo follow up visit
Not attended follow up visit and spirometry 
n = 44
Attended follow up visit and spirometry 
n = 15
p
sex (F/M) 12/32 4/11 1.0
age (years) 57.0 (51.5–61.5) 66.0 (51.0–70.0) 0.02
BMI (kg/m2) 26.1 (24.7–29.9) 26.9 (21.8–33.2) 0.94
FEV1 (L) 2.4 (1.8–2.8) 2.3 (1.6–3.0) 0.65
FEV1 (% of predicted) 76.0 (66.5–91.5) 78.0 (59.0–107.0) 0.55
FVC (L) 3.7 (3.1–4.4) 3.6 (2.6–4.4) 0.61
FVC (% of predicted) 99.0 (87.5–112) 98.5 (88.0–124.0) 0.58
FEV1%FVC 66.5 (56.5–69.5) 65.0 (52.0–69.0) 0.65
Ex-smokers/smokers 8/36 5 / 10 < 0.001
Pack-years 31.0 (25.0–40.0) 30.0 (20.0–40.0) 0.52
CAT (points) 10.0 (4.5–16.5) 11.0 (8.0–17.0) 0.39
mMRC 0.0 (0.0–2.0) 0.0 (0.0–1.0) 0.51
COPD n (%) 3 (6.8) 2 (13.3) 0.44
Asthma n (%) 1 (2.3) 1 (6.7) 0.42
The results are presented as median (IQR). Results were considered statistically significant at p < 0.05. AO — airway obstruction; BMI — body mass index; CAT 
— COPD Assessment Test; FEV1 — forced expiratory volume at 1 second; FVC — forced vital capacity; mMRC — Medical Research Council scale of dyspnea; PAO 
— possible airway obstruction
Figure 1. Flow chart presenting the number of patients and the results of spirometry in the subsequent phases of the study 
symptoms and perform a screening spirometry, 
but also to carry out an anti-tobacco educational 
campaign and to discuss threats related to smo-
king. To our knowledge, most of the previous 
studies were performed in primary care setting 
with active patient recruitment through invitation 
letters sent by post, telephone calls, advertise-
ments or encouragements during primary care 
visits [13]. Different patient characteristics and 
different model of screening can be responsible 
for significant variability in the response rate 
found in public campaigns and in screening 
programs conducted in health care centers. 
For example, approximately 70% of potentially 
eligible participants were recruited by general 
practitioners in one recent Croatian study aimed 
at the evaluation of the diagnostic accuracy of 
active screening for COPD [14], while the respec-
tive percentage in our public project conducted 
by medical students was much lower and did 
not exceed 20%. Acceptable response rates vary 
depending on the method of recruitment applied. 
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Figure 3. The differences between the results of symptoms scoring 
with mMRC and CAT in 15 patients who attended follow-up visit
Figure 2. Distribution of the analyzed group depending on the grade of the intensity of the symptoms evaluated in COPD Assessment Test
It is thought that 50% is an adequate response 
rate in patients invited to participate by mail and 
80% is considered satisfactory when the recruit-
ment is conducted on a phone call basis. When 
face-to-face contact is applied in the recruitment 
phase, the expected response rate can be as high 
as 80–85% [15]. Thus, it must be admitted that 
our response rate of 20% was unexpectedly low. 
This can be explained by several factors. First, the 
passers-by recruited at the railway station repre-
sent a fairly specific study group, not necessarily 
caring for their health. Second, the railway station 
is a busy place, where the majority of people are 
in hurry to catch their trains, trams and buses 
and, therefore, they were reluctant to stop by in 
spirometry stand. Third, young medical students 
might have been considered not competent eno-
ugh to perform spirometry screening. This might 
have resulted in lower credibility of the campaign, 
at least for some people who declined to join the 
study. Finally, winter and spring months with 
relatively low external temperature were probably 
an unfavorable time to convince the passers-by 
to participate in the project.
Low willingness to participate in screening 
programs is not a specific feature of patients with 
high risk of pulmonary diseases. In one Polish 
study, only 169 of 850 (20%) patients with vario-
us gastrointestinal symptoms agreed to undergo 
gastroscopy. The respective percentage was hi-
gher, but still relatively low (62%), in patients 
with alarming symptoms [16]. As even the risk 
of malignancy does not prompt patients to accept 
screening tests, the response rate of 20% found 
in our study performed in busy area might not be 
as low as it seems at the first glance.
Numerous previous studies demonstrated 
a high burden of COPD and emphasized the pro-
portion of undiagnosed patients. In a German co-
hort, the prevalence of COPD classified as GOLD 
stage I was estimated at 9%, but in the Hokkaido 
cohort, this value reached even 26% [17, 18]. In one 
recent study by Fu et al. [10] undiagnosed airway 
obstruction was demonstrated in 14.6% of pa-
tients attending primary care, who had a positive 
smoking history and were older than 30 years. 
Lokke et al. [20] showed that 21.7% of 4049 sub-
jects at-risk had been newly diagnosed with COPD 
in a primary care-setting and the majority of these 
patients had mild to moderate disease. In one ear-
lier Polish study that applied spirometry screening 
to detect early stages of COPD in high-risk po-
pulations (n = 11027), airway obstruction was 
found in 30.6% of subjects aged > 40 years with 
a smoking history of 10 pack-years or longer [21]. 
In our study, the sample size was significantly 
smaller, but the same inclusion criteria identify-
ing high risk population were applied. Excluding 
5 patients with known COPD and 5 patients with 
asthma and assuming 83% of correct diagnoses of 
airflow limitation in AO group and 22% of correct 
diagnoses in PAO group, it may be speculated that 
simple public spirometry performed by medical 
students can correctly identify 11–12% of subjects 
in high risk population who had undiagnosed per-
sistent airway obstruction consistent with COPD. 
Spirometry continues to be an underutilized 
tool, despite its ease of use and increased ava-
Piotr Korczyński et al., Public spirometry campaign
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ilability in primary care. Portable spirometers 
can be conveniently used during screening pro-
grams and spirometry testing do not necessarily 
need to be performed indoors [22]. The results 
of previous studies pointed out that active case 
finding in a population at risk for COPD should 
be instituted, even using a pocket screening spiro-
meter/peak flowmeter [14, 23]. High correlations 
between the results of pulmonary function me-
asured with Spirobank hand-held spirometer and 
Jaeger MasterScope in a laboratory environment 
were demonstrated [24]. Although the number 
of patients who had undergone both screening 
and stationary spirometry in our study was rela-
tively low, the differences between FEV1 and FVC 
measured in these two different settings were 
irrelevant, p = 0.30 and p = 0.79 respectively. 
It is believed that spirometry used for screening 
purposes requires a verification in a specialized 
health center. In our study, such approach was 
particularly important in patients with public 
spirometry classified as possible airway obstruc-
tion. Airway obstruction was confirmed in only 
22% of these patients. On the other hand, airflow 
limitation was confirmed by stationary spirometry 
in as many as 5/6 (83%) of patients whose earlier 
public spirometry was classified as airway obs-
truction. These data show that public spirometry 
performed with a portable spirometer might be 
a reliable screening tool for patients with COPD. 
Our results indicate that in the population 
older than 40 years with a smoking history of >10 
pack-years, extrapolated prevalence of airway 
obstruction reaches 14.6%, whereas the percen-
tage of subjects with a new diagnosis of airway 
obstruction is approximately 10.7%. Dąbrowiecki 
et al. [25] found that airway obstruction is present 
in 34% of the subjects participating in the Polish 
Spirometry Day, a national multicenter campaign. 
Such results point out a significant underestima-
tion of the number of patients with obstructive 
lung diseases in clinical practice. Knowing how 
low percentage of people are willing to perform 
spirometry during a public campaign, it would 
be advisable to search for more effective methods 
to recruit high risk patients into spirometry 
screening programs. 
In our study, subjects with airway obstruc-
tion or possible airway obstruction had a signifi-
cantly higher CAT score than those with normal 
spirometry results. We have also shown that 
a significantly higher percentage of symptomatic 
patients were identified with the use of the CAT 
compared to the use of the mMRC scale. This mi-
ght be easily explained in the light of the results 
of earlier studies that found a  relatively weak 
correlation between mMRC and CAT [26, 27] 
and demonstrated that the CAT score correlates 
much better with St. George’s Respiratory Qu-
estionnaire (SGRQ) [26]. Disagreement between 
CAT and mMRC results is not surprising because 
these two instruments differ in their purpose and 
symptom areas that are covered. CAT score and 
its items “breathlessness” and “phlegm” were 
significantly related to spirometric diagnosis 
of COPD in a population-based sample of 532 
participants [28]. 
We are aware about some limitations of 
the study that should be mentioned. The major 
limitation is probably one of the study results, 
i.e. the low percentage of passers-by who agreed 
to participate in the study. A similar statement 
refers to the low percentage of patients who 
attended follow-up visit and underwent statio-
nary spirometry verifying the results of public 
spirometry. The low number of patients in whom 
reliable conclusion from pulmonary function te-
sting could have been established (certain airflow 
limitation or normal spirometry) did not allow to 
draw any reliable epidemiological conclusions. 
Possible causes of this situation have already 
been presented when discussing the low response 
rate in our study. Complex diagnostic criteria for 
airway obstruction, with patients classification as 
having airway obstruction or possible airway ob-
struction, may be considered as one of the study 
limitations. We realize that the quality of public 
spirometry may be suboptimal and the results of 
FEV1/FVC < 0.7 in symptomatic patients unable 
to perform spirometry of good quality should 
be a subject of particular concern. Hence, these 
cases were classified as possible airway obstruc-
tion and were to be verified during the second 
phase of the study. Unfortunately, the percentage 
of patients who responded to our invitation to 
perform high quality stationary spirometry was 
surprisingly low. 
Conclusions
The limited willingness of subjects at risk 
for COPD development to participate in public 
spirometry campaign may indicate that this is not 
an effective form of COPD screening. Smokers are 
rather reluctant to undergo complimentary spiro-
metry and pulmonary consultation, even in the 
presence of pronounced respiratory symptoms. 
Nevertheless, the study showed the incidence 
of non-diagnosed airway obstruction in smokers 
aged > 40 years 10.7%. We also demonstrated 
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that a short training performed by experienced 
technicians seems sufficient for persons who are 
not healthcare providers to perform quality spiro-
metry and to obtain reliable results. Our observa-
tions may be helpful in elaborating screening 
programs for COPD. 
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